Individualization of attention-deficit/hyperactivity disorder treatment: Pharmacotherapy considerations by age and co-occurring conditions

Authors

Greg W Mattingly, Washington University School of Medicine in St. Louis
Joshua Wilson, Washington University School of Medicine in St. Louis
Leticia Ugarte, Midwest Research Group
Paul Glaser, Washington University School of Medicine in St. Louis

Journal

CNS Spectrums

Publication Date

2020

First Page

1

Last Page

20

Document Type

Open Access Publication

DOI

10.1017/S1092852919001822

Rights and Permissions

Mattingly, G., Wilson, J., Ugarte, L., & Glaser, P. (2020). Individualization of attention-deficit/hyperactivity disorder treatment: Pharmacotherapy considerations by age and co-occurring conditions. CNS Spectrums, 1-20. doi:10.1017/S1092852919001822. © Cambridge University Press 2020. https://www.cambridge.org/core

Recommended Citation

Mattingly, Greg W; Wilson, Joshua; Ugarte, Leticia; and Glaser, Paul, "Individualization of attention-deficit/hyperactivity disorder treatment: Pharmacotherapy considerations by age and co-occurring conditions." CNS Spectrums. 1 - 20. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9373